Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-04-12 @ 4:27 AM
Study NCT ID:
NCT02866227
Status:
COMPLETED
Last Update Posted:
2018-03-09
First Post:
2016-07-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TOL-463 Phase 2 Study for Vaginitis
Sponsor:
Toltec Pharmaceuticals, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-28
First Submit QC Date:
None
Study First Post Date:
2016-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2017-07-12
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-03-08
Last Update Post Date:
2018-03-09
Last Update Post Date Type:
ACTUAL